LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response.

Townsend, Liam / Fogarty, Helen / Dyer, Adam / Martin-Loeches, Ignacio / Bannan, Ciaran / Nadarajan, Parthiban / Bergin, Colm / O'Farrelly, Cliona / Conlon, Niall / Bourke, Nollaig M / Ward, Soracha E / Byrne, Mary / Ryan, Kevin / O'Connell, Niamh / O'Sullivan, Jamie M / Ni Cheallaigh, Cliona / O'Donnell, James S

Journal of thrombosis and haemostasis : JTH

2021  Volume 19, Issue 4, Page(s) 1064–1070

Abstract: ... assessed.: Results: Increased D-dimer levels (>500 ng/ml) were observed in 25.3% patients up to 4 months ... Interestingly, we observed that 29% (n = 11) of patients with elevated convalescent D-dimers had been managed ... in COVID-19 patients who had required hospital admission and in patients aged more than 50 years (p < .001 ...

Abstract Background: Persistent fatigue, breathlessness, and reduced exercise tolerance have been reported following acute COVID-19 infection. Although immuno-thrombosis has been implicated in acute COVID-19 pathogenesis, the biological mechanisms underpinning long COVID remain unknown. We hypothesized that pulmonary microvascular immuno-thrombosis may be important in this context.
Methods: One hundred fifty COVID-19 patients were reviewed at St James's Hospital Dublin between May and September 2020 at a median of 80.5 (range 44-155) days after initial diagnosis. These included patients hospitalized during initial illness (n = 69) and others managed entirely as out-patients (n = 81). Clinical examination, chest x-ray, and 6-min walk tests were performed. In addition, a range of coagulation and inflammatory markers were assessed.
Results: Increased D-dimer levels (>500 ng/ml) were observed in 25.3% patients up to 4 months post-SARS-CoV-2 infection. On univariate analysis, elevated convalescent D-dimers were more common in COVID-19 patients who had required hospital admission and in patients aged more than 50 years (p < .001). Interestingly, we observed that 29% (n = 11) of patients with elevated convalescent D-dimers had been managed exclusively as out-patients during their illness. In contrast, other coagulation (prothrombin time, activated partial thromboplastin time, fibrinogen, platelet count) and inflammation (C-reactive protein, interleukin-6, and sCD25) markers had returned to normal in >90% of convalescent patients.
Conclusions: Elucidating the biological mechanisms responsible for sustained D-dimer increases may be of relevance in long COVID pathogenesis and has implications for clinical management of these patients.
MeSH term(s) Acute-Phase Reaction ; Aged ; COVID-19/blood ; COVID-19/rehabilitation ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Humans ; Male ; Middle Aged ; SARS-CoV-2
Chemical Substances Fibrin Fibrinogen Degradation Products ; fibrin fragment D
Language English
Publishing date 2021-03-08
Publishing country England
Document type Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID 2112661-6
ISSN 1538-7836 ; 1538-7933
ISSN (online) 1538-7836
ISSN 1538-7933
DOI 10.1111/jth.15267
Shelf mark
Zs.A 5805: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Zs.MO 295: Show issues
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top